帕尔维拉治疗

Manufacturing · Pharmaceutical Preparations

完成交易日收盘US$152.93+4.51%行情日期 2026-11-03 · 非实时

公开资料页汇总帕尔维拉治疗（PVLA）的已发布行情、估值、风险、财务摘要与同业对比。行情截至2026-11-03，非实时；缺失值不按零处理。

股价走势

复权收盘价（美元）

2025-10-31 — 2026-11-03253 个交易日样本

查看交易日数据

2026-11-03PVLAUS$152.93

查看图表数据

日期	PVLA
2025-10-31	79.84
2025-11-03	76.84
2025-11-04	75.06
2025-11-05	75.75
2025-11-06	78.63
2025-11-07	77.83
2025-11-10	80.29
2025-11-11	77.85
2025-11-12	81.54
2025-11-13	80.5
2025-11-14	83.72
2025-11-17	81.64
2025-11-18	82.94
2025-11-19	96.91
2025-11-20	91.54
2025-11-21	94.09
2025-11-24	98.03
2025-11-25	94.87
2025-11-26	99.99
2025-11-28	102.79
2025-12-01	94.53
2025-12-02	91.59
2025-12-03	91.91
2025-12-04	93.8
2025-12-05	100.49
2025-12-08	100.91
2025-12-09	98.99
2025-12-10	97.43
2025-12-11	96.78
2025-12-12	98.58
2025-12-15	88.98
2025-12-16	96.81
2025-12-17	92.01
2025-12-18	96.24
2025-12-19	99.73
2025-12-22	109.07
2025-12-23	100.27
2025-12-24	105.83
2025-12-26	103.37
2025-12-29	101.15
2025-12-30	99.88
2025-12-31	104.67
2026-01-02	100.28
2026-01-05	88.44
2026-01-06	90.43
2026-01-07	101.03
2026-01-08	97.38
2026-01-09	92.41
2026-01-12	100.49
2026-01-13	103.54
2026-01-14	105.3
2026-01-15	103.98
2026-01-16	99.73
2026-01-20	98.01
2026-01-21	93.92
2026-01-22	92.08
2026-01-23	85.3
2026-01-26	86.98
2026-01-27	83.97
2026-01-28	78.71
2026-01-29	81.9
2026-01-30	76.69
2026-02-02	79.9
2026-02-03	79.91
2026-02-04	82.01
2026-02-05	76.43
2026-02-06	82.2
2026-02-09	77.88
2026-02-10	81.01
2026-02-11	79.14
2026-02-12	82.02
2026-02-13	81.54
2026-02-17	80.09
2026-02-18	79.6
2026-02-19	82.33
2026-02-20	85.66
2026-02-23	87.84
2026-02-24	120.41
2026-02-25	128.6
2026-02-26	148.34
2026-02-27	135.02
2026-03-02	132.61
2026-03-03	131.51
2026-03-04	135.49
2026-03-05	134.95
2026-03-06	134.39
2026-03-09	136.7
2026-03-10	142.11
2026-03-11	139.69
2026-03-12	136.6
2026-03-13	122.06
2026-03-16	126.05
2026-03-17	120.8
2026-03-18	114.23
2026-03-19	113.91
2026-03-20	112.5
2026-03-23	117.04
2026-03-24	116.23
2026-03-25	120.39
2026-03-26	117.61
2026-03-27	112.37
2026-03-30	110.66
2026-03-31	124.65
2026-04-01	120.38
2026-04-02	123.46
2026-04-06	119.86
2026-04-07	120.03
2026-04-08	123.17
2026-04-09	130.2
2026-04-10	127.12
2026-04-13	129
2026-04-14	129.53
2026-04-15	128.63
2026-04-16	124.18
2026-04-17	130.01
2026-04-20	129.33
2026-04-21	130.65
2026-04-22	130.64
2026-04-23	127.05
2026-04-24	123.59
2026-04-27	128.64
2026-04-28	125.96
2026-04-29	122.44
2026-04-30	128.32
2026-05-01	126.84
2026-05-04	127.61
2026-05-05	129.47
2026-05-06	130.17
2026-05-07	113.26
2026-05-08	121.29
2026-05-11	122.09
2026-05-12	125.79
2026-05-13	120.57
2026-05-14	118.97
2026-05-15	114.24
2026-05-18	105.05
2026-05-19	109.2
2026-05-20	115.5
2026-05-21	115.92
2026-05-22	113.99
2026-05-26	117.59
2026-05-27	116.26
2026-05-28	115.86
2026-05-29	118.46
2026-06-01	112.59
2026-06-02	104.67
2026-06-03	115.42
2026-06-04	114.82
2026-06-05	108.67
2026-06-08	105.25
2026-06-09	104.37
2026-06-10	102.19
2026-06-11	106.38
2026-06-12	108.81
2026-06-15	116.51
2026-06-16	110.12
2026-06-17	112.63
2026-06-18	113.1
2026-06-22	118.84
2026-06-23	118.68
2026-06-24	129.84
2026-06-25	136.2
2026-06-26	148.21
2026-06-29	154.84
2026-06-30	152.82
2026-07-01	138.26
2026-07-02	146.76
2026-07-06	140.31
2026-07-07	145.7
2026-07-08	145.19
2026-07-09	151.04
2026-07-10	144.76
2026-07-13	146.03
2026-07-14	149.68
2026-07-15	151.97
2026-07-16	147.77
2026-07-17	157.24
2026-07-20	124.15
2026-07-21	143.94
2026-07-22	142.18
2026-07-23	143.21
2026-07-24	138.01
2026-07-27	141.77
2026-07-28	142.84
2026-07-29	142.6
2026-07-30	150.19
2026-07-31	139.04
2026-08-03	140.78
2026-08-04	151.99
2026-08-05	154.91
2026-08-06	154.93
2026-08-07	157.77
2026-08-10	152.22
2026-08-11	154.3
2026-08-12	155.07
2026-08-13	156.55
2026-08-14	156.13
2026-08-17	153.52
2026-08-18	150.42
2026-08-19	149.96
2026-08-20	142.58
2026-08-21	142.04
2026-08-24	145.75
2026-08-25	148.24
2026-08-26	154.33
2026-08-27	150.33
2026-08-28	149.97
2026-08-31	152.59
2026-09-01	150.55
2026-09-02	152.95
2026-09-03	155.47
2026-09-04	157.24
2026-09-08	152.28
2026-09-09	151.34
2026-09-10	150.39
2026-09-11	150.13
2026-09-14	151.69
2026-09-15	151.22
2026-09-16	151.43
2026-09-17	154.32
2026-09-18	150.56
2026-09-21	153.41
2026-09-22	158.13
2026-09-23	149.56
2026-09-24	146.07
2026-09-25	138.16
2026-09-28	139.83
2026-09-29	139
2026-09-30	137.93
2026-10-01	132.73
2026-10-02	132.47
2026-10-05	132.16
2026-10-06	128
2026-10-07	130.59
2026-10-08	131.34
2026-10-09	138.77
2026-10-12	134.38
2026-10-13	128.51
2026-10-14	122.58
2026-10-15	127.34
2026-10-16	120.3
2026-10-19	122.96
2026-10-20	123.92
2026-10-21	126.58
2026-10-22	126.39
2026-10-23	125.1
2026-10-26	126.23
2026-10-27	132.91
2026-10-28	147.47
2026-10-29	151.58
2026-10-30	146.15
2026-11-02	146.33
2026-11-03	152.93

1、3、6、12个月分别按21、63、126、252个交易日取区间；缺失日期不从区间外补齐。

使用已有每日复权收盘样本，非实时行情；图中价格可能与未复权收盘报价不同。

01 · MARKET FRAME

行情、估值与风险

基于已完成交易日和已发布财务资料

市值US$2.2B

市盈率（TTM）—

自由现金流收益率—

距52周高点-3.3%

近一年波动率+83.1%

近一年最大回撤-31.1%

区间涨跌幅

10日+23.4%起点 2026-10-20

30日-3.3%起点 2026-09-22

90日+3.2%起点 2026-06-26

180日+91%起点 2026-02-17

250日+103.7%起点 2025-11-04

区间涨跌幅使用复权收盘价；估值和风险指标缺失时显示为—，不按零处理。

02 · FINANCIAL TRACE

财务摘要

公开页仅显示最近3个已校验报告期

年度财务走势

百万美元 · 年度报告期

所选指标暂无已校验的年度资料，缺失值不按零处理。

指标	2026-07-31	2026-06-30	2025-12-31	2025-08-08	2025-06-30	2024-12-31	2024-08-08	2024-06-30	2023-12-31
营收	—	—	—	—	—	—	—	—	—
净利润	—	—	-41.7	—	—	-17.4	—	—	18.7
自由现金流	—	—	—	—	—	—	—	—	—
股份数	14.4	—	—	11.1	—	—	1.3	—	—
债务	—	—	—	—	—	—	—	—	—
总资产	—	253.5	—	—	73.7	—	—	25.1	—

金额及股份数均以百万为单位。缺失或待核验数据不按零处理。

03 · PEER SET

同业对比

同一细分行业中市值最接近的公司

公司	市值	近250日涨跌幅	市盈率	距52周高点	波动率
VERA维拉治疗	US$2.2B	+26.1%	—	-44.8%	+61.6%
AUPH奥瑞尼亚	US$2.2B	+16.1%	7×	-11.1%	+36.6%
PRGO培瑞克	US$2.2B	-14.9%	—	-17.1%	+55.9%
HRMY哈莫尼生物科学	US$2.2B	+20.5%	11.9×	-13.6%	+39.9%

同业由已覆盖公司的行业分类和市值接近度确定，仅用于横向研究；缺失数据不按零处理。